Case studies

Please select a Case Study from the list below.

Hepatocellular Carcinoma (HCC) Embolisation using DC Bead Doxorubicin
Professor Anthony Watkinson, Consultant Radiologist, Royal Devon and Exeter Hospital, Exeter, UK - August 2007

Trans-Arterial Chemo-Embolisation of Metastases from a Choroid Melanoma
Jakub Wiskirchen, MD, Gunnar Tepe, MD, and Philippe L. Pereira, MD; Department for Diagnostic and Interventional Radiology, University Hospital Tübingen, Germany - August 2007

Trans-Arterial Chemo-Embolisation of a Diffuse/Multifocal Hepatoma
Jakub Wiskirchen, MD, Gunnar Tepe, MD, and Philippe L. Pereira, MD; Department for Diagnostic and Interventional Radiology, University Hospital Tübingen, Germany - August 2007

Trans-Arterial Chemo-Embolisation of a Hepatoma
Jakub Wiskirchen, MD, Gunnar Tepe, MD, and Philippe L. Pereira, MD; Department for Diagnostic and Interventional Radiology, University Hospital Tübingen, Germany - August 2007

Trans-Arterial Chemo Embolisation (DC Bead) of a Hepatoma
Jakub Wiskirchen, MD, Gunnar Tepe, MD, and Philippe L. Pereira, MD; Department for Diagnostic and Interventional Radiology, University Hospital Tübingen, Germany - February 2007

Trans-Arterial Chemo Embolisation (DC Bead) of Metastases from a Choroid Melanoma
Jakub Wiskirchen, MD, Gunnar Tepe, MD, and Philippe L. Pereira, MD; Department for Diagnostic and Interventional Radiology, University Hospital Tübingen, Germany - February 2007

Trans-Arterial Chemo Embolisation (DC Bead) of a Diffuse or Multifocal Hepatoma
Jakub Wiskirchen, MD, Gunnar Tepe, MD, and Philippe L. Pereira, MD; Department for Diagnostic and Interventional Radiology, University Hospital Tübingen, Germany - February 2007

Regulatory Notices

Worldwide (excluding USA and Canada)

DC Bead® is CE marked and is indicated for the treatment of malignant hypervascular tumours and loading with doxorubicin drug. DC Bead® is also indicated for loading with irinotecan for the treatment of metastatic colorectal cancer (mCRC). For full prescribing information please refer to DC Bead instructions for use.

USA

DC Bead is not currently available for sale or distribution in the USA. DC Bead has not been submitted for approval to the FDA.

Canada

DC Bead® with doxorubicin is indicated for trans-arterial chemoembolization (TACE) of unresectable hepatocellular carcinoma (HCC). DC Bead are also intended to be loaded with irinotecan for the purpose of embolization of vessels supplying malignant colorectal cancer metastasised to the liver (mCRC), and delivery of a local, controlled, sustained dose of irinotecan to the mCRC. For full prescribing information please refer to DC Bead Canada Instructions for Use 

Tawain

DC Bead is approved by the Department of Health and is intended to be loaded with Mayne (Hospira) doxorubicin HCI for the purpose of embolisation of vessels supplying malignant hypervascularised tumour(s), and delivery of a local, controlled, sustained dose of doxorubicin.  DC Bead is also indicated for the embolisation of nidus vessels without medication.  Approved size ranges in Taiwan are 300-500µm and 500-700µm.